Berry Institute Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4699 Charleston Hwy, Rowesville, SC 29133 Phone: 803-347-3329 |
Jessica Berry Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4699 Charleston Hwy, Rowesville, SC 29133 Phone: 843-906-7105 |
News Archive
Researchers at Queen Mary University London and the University of Leicester and have announced a potential breakthrough in the treatment of a rare but devastating medical condition that can affect children and young people.
TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB drug candidate to begin a Phase 1 clinical trial since 2009.
Writing in the Global Health Technologies Coalition's (GHTC) "Breakthroughs" blog, GHTC Communications Officer Kim Lufkin summarizes the group's annual congressional briefing, "which focused on how U.S. policymakers can protect the nation's investments in global health research in upcoming budget discussions."
Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.
Short-term hearing loss during childhood may lead to persistent hearing deficits, long after basic auditory sensitivity has returned to normal. The processing of sound in the brain is shaped by early experience.
› Verified 3 days ago